This message was sent to ##Email##
|
|
|
|
|
AST
The Donation Derby is a contest that supports the AST and the initiatives of your COPs. Every donation made to the AST by COP members until December 31 at 11:59 PM ET will count toward the contest.
READ MORE
AST
Join us for an interactive discussion on organ allocation at the 2020 Cutting Edge of Transplantation (CEoT) meeting in Phoenix, AZ. Early bird registration is now open.
READ MORE
AST
The AST sponsors a variety of Achievement Awards in recognition of AST members' achievements and contributions to the field of transplantation. The AST encourages members to nominate deserving candidates for consideration. Make your nominations by January 31.
READ MORE
 |
|
Promoted by
Veloxis Pharmaceuticals
Explore some of the many factors that can put a graft at risk, including CYP3A5*1 expression, declining adherence, and nephrotoxicity. In addition, review pharmacokinetic and clinical data that may be relevant to your practice and patients.
See the Video
|
|
AST
The Fellow of the American Society of Transplantation (FAST) designation application is now open to all members who meet the eligibility criteria. Instructions for the application can be found here. The deadline to apply is January 15, 2020. Don't miss out on joining this prestigious program and be recognized for your contributions to transplantation.
READ MORE
AST
The AST’s Trainee and Young Faculty COP created a brand-new user guide for new AST members. If you are a new AST member, or if you would like to learn more, this guide will help you get the most out of your membership.
READ MORE
AST
The Transplant Nephrology Core Curriculum (TNCC) is an online program jointly provided by the American Society of Nephrology and the American Society of Transplantation. The TNCC focuses on key information needed to prepare for the American Board of Internal Medicine Nephrology Board Certification and Maintenance of Certification examinations.
READ MORE
AST
Transplant professionals have increasing demands on their time. Finding time in one’s day to attend conferences or to read journals is challenging. Transplant in 10 is intended to provide transplant professionals with short, easily accessible videos on key and updated topics in 10 minutes.
READ MORE
Advertisement
Veloxis Pharmaceuticals
Immunosuppressive medications can be a financial burden for kidney transplant patients, potentially costing as much as $10,000 to $14,000 a year. These expenses can have a negative impact on patients’ lives and may play a role in medication nonadherence, which is associated with transplant failure. Learn more about support that is available with a free 30-day trial to allow your patients to start immediately at no cost. And, for patients who are eligible with commercial insurance coverage, a $0 co-pay card offers significant savings.
Find out more
|
| | UPCOMING EDUCATION EVENTS |
AST
December 17, 2019 | 2 pm ET | Online Activity
For more information, click here.
AST
January 21, 2020 | 2 pm ET | Online Activity
For more information, click here.
|
|
American Journal of Transplantation via Wiley Online Library
The purpose of this study was to assess the availability of mental health and chemical dependency services at U.S. transplant centers, because appropriate psychosocial assessment and care is associated with better transplant outcomes. We used the 2017‐18 American Hospital Association survey, Area Health Resource File and Centers for Medicare & Medicaid Services Hospital Compare databases to quantify availability of services and examined associations of hospital‐ and health services area‐level characteristics with odds of offering services with generalized linear mixed models.
READ MORE
American Journal of Transplantation via Wiley Online Library
Diagnosing lung transplant rejection currently depends on histologic assessment of transbronchial biopsies (TBB) with limited reproducibility and considerable risk of complications. Mucosal biopsies are safer but not histologically interpretable. Microarray‐based diagnostic systems for TBBs and other transplants suggest such systems could assess mucosal biopsies as well. We studied 243 mucosal biopsies from the third bronchial bifurcation collected from seven centers and classified them using unsupervised machine learning algorithms.
READ MORE
|
KidneyCare combines clinically validated AlloSure testing with AlloMap kidney and iBox to deliver personalized and Prognostic solutions for transplant patients.
Learn More
|
|
|
|
|
TruGraf® - The 1st and only non-invasive test to rule out “silent" subclinical rejection in stable kidney transplant recipients
The only test to be reimbursed as an alternative to surveillance biopsies
Developed by Clinicians for Clinicians
Learn More
|
|
|
|
|
American Journal of Transplantation via Wiley Online Library
Living organ donors face direct costs when donating an organ, including transportation, lodging, meals, and lost wages. For those most in need, the National Living Donor Assistance Center provides reimbursement to defray travel and subsistence costs associated with living donor evaluation, surgery, and follow‐up. While this program currently supports 9% of all U.S. living donors, there is tremendous variability in its utilization across U.S. transplant centers, which may limit patient access to living donor transplantation.
READ MORE
AASLD
The burden of CKD is rising among patients with cirrhosis — it is not known what impact this has had on pos-LT outcomes. All patients listed for LT in the U.S. between 2002-17 were analyzed, excluding those listed with MELD exceptions. The primary outcome was post-LT mortality. We defined CKD pre-LT as an eGFR less than 60 ml/min for 90 days OR more than or equal to 72 days of hemodialysis. Cox-regression determined the association between pre-LT CKD and post-LT mortality.
READ MORE
|
Advertisement
Decades of clinical evidence has shown that HLA-specific antibodies may lead to hyperacute antibody-mediated rejection (ABMR).
Today, ABMR remains a major challenge to successful transplantation, but detection of donor specific antibodies (DSA) is the best tool for stratifying risk. LABScreen Single Antigen Beads remain the worldwide leader for the detection of DSA.
Learn More
|
|
|
|
|
Reach Your Prospects Every Week
Thousands of industry professionals subscribe to association news briefs, which allows your company to push messaging directly to their inboxes and take advantage of the association's brand affinity.
Connect with Highly Defined Buyers and Maximize Your Brand Exposure
|
|
|
|
|
Clinical Key
The popular sense of the word "cure" implies that a patient treated for a specific disease will return to have the same life-expectancy as if he/she had never had the disease. Read the full accepted manuscript from Clinical Key. The cure model suggests that resection can provide the same life-expectancy of patients with chronic hepatitis — cirrhosis in 26.3% of cases, and the same life-expectancy of general population in 17.1%. Patients resected in the most recent years had higher cure probabilities, probably due to modern effective antiviral therapies.
READ MORE
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
